Login
Search
Search
0 Dates
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
Prognostic role of non-sustained ventricular tachycardia in nonischemic cardiomyopathy
Session:
Posters - C. Arrhythmias and Device Therapy
Speaker:
M. Inês Barradas
Congress:
CPC 2021
Topic:
C. Arrhythmias and Device Therapy
Theme:
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
Subtheme:
08.2 Ventricular Arrhythmias and SCD - Epidemiology, Prognosis, Outcome
Session Type:
Posters
FP Number:
---
Authors:
M. Inês Barradas; Fabiana Duarte; Luís Oliveira; Cátia Serena; António Fontes; André Monteiro; Carina Machado; Raquel Dourado; Emília Santos; Nuno Pelicano; Miguel Pacheco; Anabela Tavares; Dinis Martins
Abstract
<p style="text-align:start"><span style="font-size:medium"><span style="font-family:Calibri"><span style="color:#000000"><strong><span style="color:black">Background:</span></strong><span style="color:black"> Assymptomatic </span><span style="color:black"><span style="background-color:white">non-sustained ventricular tachycardia</span></span><span style="color:black"> (NSVT) is a common finding in Heart Failure (HF) patients with cardiac implantable electronic devices (CIEDs). In ischemic cardiomyopathy (ICM) NSVT has a well-known prognosis impact but, in nonischemic cardiomyopathy (NICM) its clinical importance and prognosis impact is less well stablished. </span></span></span></span></p> <p style="text-align:start"> </p> <p style="text-align:start"><span style="font-size:medium"><span style="font-family:Calibri"><span style="color:#000000"><strong><span style="color:black">Purpose:</span></strong> <span style="color:black"><span style="background-color:white">To determine the prognostic impact of NSVT detection in nonischemic cardiomyopathy patients.</span></span></span></span></span></p> <p style="text-align:start"> </p> <p style="text-align:start"><span style="font-size:medium"><span style="font-family:Calibri"><span style="color:#000000"><strong><span style="color:black">Methods: </span></strong><span style="color:black"><span style="background-color:white">We retrospectively enrolled 70 consecutive NICM patients with systolic left ventricle dysfunction and CIEDs (biventricular pacemakers with or without cardiac defibrillators). Patients were evaluated through CIEDs interrogation and clinical evaluations and divided into NSVT positive (Group 1) and negative groups (Group 2). Mean follow-up period was 59,3 </span></span><span style="font-family:Symbol"><span style="color:black"><span style="background-color:white">±</span></span></span><span style="color:black"><span style="background-color:white"> 44,1 months.</span></span></span></span></span></p> <p style="text-align:start"> </p> <p style="text-align:start"><span style="font-size:medium"><span style="font-family:Calibri"><span style="color:#000000"><strong><span style="color:black"><span style="background-color:white">Results: </span></span></strong></span></span></span><span style="font-size:medium"><span style="font-family:Calibri"><span style="color:#000000"><span style="color:black"><span style="background-color:white">Mean age was 68,9 </span></span><span style="font-family:Symbol"><span style="color:black"><span style="background-color:white">±</span></span></span><span style="color:black"><span style="background-color:white"> 13,1 years and 57,1% were males 57,1%. In 64,3% of the patients the etiology was idiopathic, 17,1% </span></span><span style="color:black">alcoholic cardiomyopathy, 4,3% familial dilated cardiomyopathy</span><span style="color:black"><span style="background-color:white"> and 2,9% valvular. The two groups were well matched with no significant difference with regard to age, gender, comorbidities, aetiology of HF and NYHA class and left ventricular ejection fraction (LVEF). In total 8 (11,4%) patients died, 2 (2,9%) from sudden cardiac death and 5 (7,1%) from cardiovascular death. </span></span></span></span></span><span style="font-size:medium"><span style="font-family:Calibri"><span style="color:#000000"><span style="color:black"><span style="background-color:white">NSVT was associated with sustained ventricular tachycardia (VT) (hazard ratio </span></span><span style="font-family:Symbol"><span style="color:black"><span style="background-color:white">[</span></span></span><span style="color:black"><span style="background-color:white">HR</span></span><span style="font-family:Symbol"><span style="color:black"><span style="background-color:white">]</span></span></span><span style="color:black"><span style="background-color:white"> 20,235; 95% confidence interval </span></span><span style="font-family:Symbol"><span style="color:black"><span style="background-color:white">[</span></span></span><span style="color:black"><span style="background-color:white">CI</span></span><span style="font-family:Symbol"><span style="color:black"><span style="background-color:white">]</span></span></span><span style="color:black"><span style="background-color:white">: 2,349-174,301; p=0,001), ventricular fibrillation (HR: 0,360; 95% CI: 0,213-0,607; p=0,026) and CIEDs treatments (HR: 5,295, CI 1,432-19,569; p=0,012). NSVT was associated with composite outcome of VT, VF, HF re-admissions and related admissions to emergency department (ED) and death by all causes (HR: 3,252;</span></span><span style="color:black"> <span style="background-color:white">95% CI: 1,182-8,948; p=0,020).</span></span></span></span></span></p> <p style="text-align:start"> </p> <p style="text-align:start"><span style="font-size:medium"><span style="font-family:Calibri"><span style="color:#000000"><strong><span style="color:black">Conclusion: </span></strong><span style="color:black">NSVT was significantly associated with adverse outcome, arrhythmic events and CIEDs treatments in NICM, which enhances the potential benefits of ICD in these patients and could be used as a potentially predictor of arrhythmic events. </span></span></span></span></p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site